Rex-1 (Zfp-42) is a known marker for undifferentiated embryonic stem cells and teratocarcinoma cells. However, the mechanism through which Rex-1 is regulated in pluripotent cells remains unresolved. Here we report that Nanog, an Nk-2 homeodomain protein known for its role in maintaining stem cell pluripotency, is a transcription activator for the Rex-1 promoter. Knockdown of Nanog in ES cells resulted in reduction of Rex-1 expression while forced expression of Nanog in P19 stimulated Rex-1 expression. Employing a Rex-1 reporter, we demonstrate that Nanog transactivates Rex-1 directly. Serial deletion studies mapped the Nanog responsive element between -187 to -286 of the Rex-1 promoter. While Oct3/4 and Sox2 can both transactivate Rex-1 promoter, only Sox2 cooperates with Nanog in upregulating Rex-1. Furthermore, we demonstrated that the C-terminus of Nanog is responsible for transactivating the Rex-1 promoter, a function that can be substituted by a viral transactivator VP16 efficiently in NIH3T3 cells, but less in P19.
INTRODUCTION
The Rex-1 gene is a developmentally regulated acidic zinc finger gene (Zfp-42) and a well recognized marker for the pluripotent state of both embryonic stem (ES) cells and embryonic carcinoma (EC) cells (1, 2) . Both EC and ES cells can be induced to differentiate into primitive endoderm-like cells by the treatment of retinoic acid (RA) with the down-regulation of pluripotency markers such as Rex-1 (1) (2) (3) . In addition to being a well known pluripotent marker, Rex-1 has also been implicated in regulating the pluripotent state. F9 cells lacking both alleles of Rex-1 (Rex-1 -/-) differentiate into the parietal endoderm (PE) as indicated by the expression of several PE markers such as thrombomodulin and laminin B1 upon RA induction, while wild type F9 cells require both RA and cyclic AMP analogs to differentiate into PE (4) . On the other hand, F9 Rex-1 -/-cells were unable to differentiate along several distinct cell lineages in early embryogenesis (4) . The molecular mechanism governing the expression of Rex-1 during early development and differentiation remains largely unknown.
The promoter of Rex-1 has been shown to contain an octamer motif that is required for its activity in undifferentiated F9 cells and involved in RA-mediated downregulation (5) . Subsequent analysis has demonstrated that Oct-3/4 and Oct-6 can regulate the activity of Rex-1 promoter through this octamer motif in a dose-dependent manner (6) . Sox2, a member of the HMG-domain DNA binding-protein family, forms a ternary complex with OCT-3/4 protein on the enhancer element of Fgf4 and regulates its expression as a binary complex (13, 14) . Nanog is a newly identified transcription factor that maintain mouse ES cells in pluripotent state independent of LIF (7, 8) . Upon differentiation, ES cells lose the expression of Nanog (8) . We have recently demonstrated that Nanog functions as a transcription activator through binding to a consensus recognition motif determined by SELEX, despite the fact that Nanog was originally proposed as a transcription repressor to inhibit the expression of genes important for cell differentiation (7, 9, 10) . Interestingly, Nanog is regulated by an adjacent pair of highly conserved Octamerand Sox-binding sites through an interaction between Oct-3/4 and Sox2 (15) . Our recent work has demonstrated that transcription factors Oct4, Nanog, Sox2 and FoxD3 anchor a negative feedback loop to maintain the expression of pluripotent factors at a steady state (manuscript in press). In this report, we present evidence that Rex-1 is regulated by Nanog, Oct4 and Sox2 at the transcription level. The expression plasmid Nanog, Oct-3/4, Sox2, Dmu-mSox2 and FoxD3 has been described or will be detailed elsewhere (10, Manuscript in revision). Nanog-GFP was made by cloning the full length Nanog cDNA into EcoR V site in frame to a flag and GFP coding sequence in vector-pCR3.1. Nanog N1 was described previously (10) . The Vp16 chimera was prepared by inserting a PCR fragment encoding amino acids of Vp16 activation domain to the modified N1 mutant. Rex-1 promoter fragments were amplified by PCR from the mouse liver genome DNA and inserted to the SmaI site of a promoter less luciferase reporter vector pGL3-Basic (Promega, Madison, WI). The primers were: Forward: 5' ccttgccacagc ctcaccctgatag3' for the promoter of 1500bp Rexp1500 (5'cggctgccaatgcattttttaaaacgc 3' for the promoter of 1000bp, Rexp1000; The chromatin preparations were divided into three portions. One portion was precipitated with Nanog antibody (5 ul), the second option was precipitated with nonimmune antibody as control, the 3 rd one was stored as input (the positive control for further experiments), at 4℃ on a rotator overnight. The complexes were absorbed in 40ul proteinA/G Plus-Agrose (Santa Cruz, CA) and 20ug Herring Sperm DNA (Promega) per sample and incubation for 1-2 hours at 4℃. The resins were then washed 1x with PBS, 1x with high salt wash buffer (1% Triton X-100, 0.1% Deoxycholate, 50mM Tris 8.1, 150mM NaCl, 5mM EDTA) and 1x with PBS. The complexes were eluted by 500ul elution buffer (1% SDS, 0.1M NaHCO 3 , 0.01mg/ml Herring Sperm DNBA). Then the cross-links were reversed by adding 20ul NaCl per sample and incubate at 65 ℃ for 3-4 hours. After digestion with proteinase K for 1h at 55℃, DNAs were extracted and precipitated before being analyzed by PCR using the primers: Forward: 5' gaggtactgagatgtgact gagtctca3' Reverse: 5' ctccttggacccctccctttt tagatg 3'.
EXPERIMENTAL PROCEDURES

RESULTS
Regulation of Rex-1 expression by Nanog -Nanog and Rex-1 are two transcription factors whose mRNA are expressed at relatively high levels in pluripotent cells, including ES cells and F9 EC cells, but diminished during the differentiation of these ES and EC cells or normal embryonic development (1, 2, 8) . As Nanog is a critical factor in maintaining the self-renewal of ES cells and Rex-1 is a commonly used ES cell marker gene (1, 7, 8) , we attempted to establish a regulatory relationship between them. We first knocked down the expression of Nanog in ES cells by siRNA constructs (16) and extracted the RNA from the ES cells transfected with either the control vector (pBSU6 vector) or the Nanog siRNA construct (16) 72 h after the transfection for RT-PCR analysis. As shown in Fig. 1A , the Nanog siRNA inhibited the expression of endogenous Nanog as expected (bottom panel, lanes 3 vs 2). Interestingly, the mRNA of Rex-1 was also inhibited in the ES cells transfected with the Nanog siRNA construct (middle panel, lanes 3 vs 2), suggesting that Rex-1 is regulated by Nanog.
One may argue that the decline of Rex-1 expression in ES cells with Nanog knocked-down (Fig. 1A ) may be the consequence of ES differentiation triggered by the suppression of Nanog expression by Nanog siRNA.
To establish a direct relationship between Nanog and Rex-1, we activated Rex-1 by Nanog in cells that normally express no Rex-1 or very little of it. Indeed, P19 cells appear to express no detectable Rex-1 mRNA (1), and much reduced level of Nanog as well (8) . To this end, we transfected P19 cells with either pCR3.1GFP or CR3.1-NanogGFP and extracted their RNAs 48 h post-transfection for RT-PCR analysis. As shown in Fig. 1B , we observed the induction of Rex-1 by Nanog in P19 cells (middle panel, lanes 3 vs 2), while the mRNAs for actin are comparable in both cells and those for Nanog elevated as expected (top and bottom panels).
Since Rex-1 expression decreases during retinoic acid induced differentiation in F9 cell, we then determined the expression kinetics of both Nanog and Rex-1 during F9 cell differentiation. As shown in Fig1C, both Rex-1 and Nanog declined about 40% after 48 h of RA treatment (lanes 3 vs 1). Between 48 to 72 hours (lanes 3, 4), Nanog mRNA declined faster than that of Rex-1 during the RA treatment and the level of Rex-1 and Nanog mRNAs both declined to about 20% at 96 h (lanes 5 vs 1). These results suggest that Nanog regulates the expression of Rex-1, perhaps, in conjunction with other regulatory proteins.
Nanog activates the Rex-1 promoter in both differentiated and pluripotent cells -We then screened several more cell lines for Rex-1 expression by RT-PCR. As shown in Fig. 2A 5 vs 2, 3 ). This expression pattern suggests that Rex-1 is regulated differentially in these cells. Furthermore, these cell lines could serve as models to characterize the mechanism of Rex-1 regulation. To this end, we cloned a 1529bp long promoter of Rex-1 into pGL-Basic vector bearing the luciferase reporter (Fig. 2B) , and designated it as Rexp1500. As shown in Fig. 2C , the activity of this reporter functions as expected with relatively high activities in F9 and ES cells, no or lower activities in P19 and NIH3T3 cells, in agreement with the Rex-1 mRNA levels shown in Fig. 2A .
To test if Nanog can transactivate Rex-1 promoter directly, we cotransfected the Rex-1 reporter together with the control or Nanog expression constructs into NIH, P19 and F9 cells. Luciferase activities in these cells were determined, normalized (with Renilla) and presented in Fig2.D. Nanog up-regulated the Rex-1 reporter significantly in NIH cells (>3 folds), P19 (1.5 fold) and F9 (1.4 fold) compared to the control expression vector (Fig. 2D, lanes 2, 4,  6 , vs 1, 3, 5). Although Nanog can activate Rex-1 promoter in both differentiated cells (NIH cell) and pluripotent cells (P19 cell and F9 cell), the magnitude of activation appears to be greater in NIT3T3 cells than in P19 and F9 cells, perhaps due to the high endogenous levels of Nanog in both cells (data not shown). To test this possibility, we tested the dependence of Rex-1 expression on Nanog by knocking down Nanog through siRNA in F9 cells. We considered F9 cells as an ideal model because of high levels of expression for both endogenous Nanog and Rex-1 mRNAs (8).
First, we tested the efficiency of Nanog knockdown by extracted the mRNA of the cells transfected with pBSU6-GFP and siNanog. As shown in Fig. 2F , Nanog siRNA inhibited most of the expression of endogenous Nanog after 24 hr transfection (the first panel, lane 3 vs 2). Then we cotransfected the Rex-1 reporter construct with control and the Nanog siRNA constructs into F9 cells and measured luciferase activities 24 hr later. As shown in Fig. 2E , the Nanog siRNA construct inhibited the Rex-1 reporter significantly (3.8 fold) compared to the control siRNA vector (lanes 3 vs 2), demonstrating that Nanog plays an important role in sustaining Rex-1 promoter activity.
Localization of Nanog responsible element between -187 to -286 in Rex-1 promoter -Recent evidence from our group demonstrated that Nanog activates a reporter construct bearing multiple copies of its consensus binding motif (9) , suggesting that Nanog activates its downstream target directly through DNA binding. To localize the DNA sequence that is responsive to Nanog mediated activation, we generated a series of promoter deletion constructs as shown in Fig. 3A , bearing Rex-1 promoter sequences up to -1000, -500, -286 and -187 from the transcription start site at +1 respectively.
To assess their responsiveness to Nanog, we transfected these deletion constructs with Nanog expression vector into P19 cells. A constant amount (0.25ug) of each deletion Rex-1 promoter construct was cotransfected with control vector (Fig. 3B, lanes 1, 5, 9 , 13, 17) or increasing amounts of the Nanog expression construct (Fig. 3B, lanes 2-4, 6-8,  10-12, 14-16, 18-20) , respectively, to measure a dose-dependent activation of the reporter by Nanog in P19 cells. As shown in Fig. 3B , the luciferase activities driven by by guest on November 15, 2017 http://www.jbc.org/ Downloaded from Rexp1500, Rexp1000, Rexp500 and Rexp286 Rex-1 promoter sequences were stimulated by Nanog in a dose dependent fashion (lanes 5-20), while those by Rexp187 were not (lanes 1-4) . Therefore, these results suggest that Nanog may bind to the Rex-1 promoter between -187 to -286. Interestingly, the luciferase activities driven by Rexp1500 and Rexp1000 were less responsive than the Rexp500 and Rexp286 to Nanog, suggesting that additional effectors may modify the Nanog-mediated activation of Rex-1.
Nanog has been shown to bind a ATTC-containing motif (17) . We then screened the Rex-1 promoter between -187 to -286 for and found a similar motif at -244.
To determine if this motif is responsible for Nanog-mediated activation of Rex-1, we designed and generated 4 mutations within this motif (Fig. 3C, upper  portion) .
Reporters bearing these mutations were analyzed by co-transfecting increasing amount of Nanog in P19 cells (Fig. 3C, lanes 2-4, 6-8, 10-12, 14-16 , 18-20). As shown in Fig. 3C , the luciferase activities driven by 286-mut-1, 286-mut-2, 286-mut-3 and 286-mut-4 mutant promoter sequences were no longer responsive to Nanog (lower portion, lane 5-20), while Rexp286 was responsive to Nanog in a dose dependent manner (lane 1-4). These results demonstrate that the ATTC motif is responsible for Nanog-mediated activation of Rex-1 promoter.
To confirm the binding of Rex-1 by Nanog inside the cells, we performed CHIP analysis in ES, F9 and NIH3T3 cells. Anti-Nanog antibody was able to precipitate the chromatin fragments bearing the 287 nt sequence of Rex-1 in ES and F9 cells while anti-IgG antibody can not as shown in Fig.  3D (the top and middle panel, lane 2 vs 1). As a negative control, no binding was observed in NIH3T3 cells, which express no detectable Nanog (the bottom panel, lane 2). These results demonstrate that Nanog binds to the Rex-1 promoter directly at -244nt.
Regulation of Rex-1 promoter by Sox2 and Oct-3/4, but not FoxD3 -Recent data from Chip-on-Chip experiments revealed that Nanog, Sox2 and Oct-3/4 co-occupy common sites on the promoter of their target genes (11) . Since Oct-3/4 can bind to the OCTA site on the Rex-1 promoter as described (6), we tested if Oct3/4 and its partner Sox2 can activate Rex-1 promoter. We cotransfected the Rexp1500 constructs with increasing amounts of either Sox2, FoxD3, or Oct-3/4 into 293T, NIH3T3 and P19 cells and measured their activities as described in Fig. 3 . As expected, Oct3/4 activated the Rex-1 promoter significantly in 293T and P19 cells, but not in NIH3T3 cells (Fig. 4A, B, C, lanes 1-4) . Interestingly, the Oct3/4 partner Sox2 activated Rex-1 promoter in an almost identical pattern (Fig.  4A, B, C, lanes1, 8-10 ), while FoxD3 did not have any effect on Rex-1 promoter in any of these cells (Fig. 4A, B, C, lanes 1,  5-7) .
These results demonstrated that whereas either Sox2 or Oct-3/4 could activate the Rex-1 promoter, Foxd-3 did not. Furthermore, neither Sox2 nor Oct-3/4 can activate Rex-1 promoter in NIH3T3 cells (Fig4.B) , in contrast to Nanog (Fig. 2D) .
We further evaluated whether Sox2 activate Rex-1 specifically. We co-transfected the Rexp500 reporter with a Sox2 mutant Dmu-mSox2 (manuscript in preparation). As expected, Dmu-mSox2 activated the Rex-1 promoter poorly in 293T cells (Fig. 4A, lanes 11-13) , but robustly in NIH3T3 and P19 cells (Fig. 4B and C, lanes  11-13) .
Given the fact that Nanog, Oct3/4 and Sox2 can all activate Rex-1 promoter, it raises the possibility that these three factors may synergize with each other. To test this possibility, we co-transfected Nanog alone or in combination with Oct3/4, Sox2 and Dmu-mSox2 with Rexp500 in 293T cells. As shown in Fig. 4D , Sox2 appear to be able to super-activate the Rex-1 promoter already activated by Nanog (lanes 3, 4 vs 2) , while the Dmu-mSox2 failed to do so. On the other hand, Oct3/4 and Nanog, Oct3/4 and Sox2 failed to achieve any additional activation beyond the activity of Oct3/4, Nanog and Sox2 alone (Data not shown). Unfortunately, the cooperativity among these three factors cannot be demonstrated in P19 cells, suggesting that additional proteins may participate in the regulation of Rex-1. Nevertheless, our data demonstrate that Nanog is able to regulate Rex-1 with Sox2.
The role of Nanog C-terminus in mediating Rex-1 activation -We have previously shown that C-terminal domain of Nanog contains the main transactivation activity towards synthetic reporter constructs bearing Nanog binding sites (9, 10) . It is not clear if the C-terminus of Nanog is responsible for the observed activation of Rex-1. To this end, we tested the N1 Nanog mutant against the Rex-1 reporter. As shown in Fig. 5B , N1 is about 1/3 as active as the wild type Nanog in activating Rexp500 in NIH3T3 cells (lanes 3 vs 1) . However, N1 appeared to be inactive against Rex-1 reporter in P19 cells (Fig. 5C, lanes 3  vs 1) . Together, these data demonstrate that the C-terminus of Nanog is required for Nanog-mediated Rex-1 activation.
Given the fact that CD2 of Nanog is a potent transactivator, even comparable to the most active known transactivator VP16 from human Herpes Virus (10), we constructed a chimera between the Nanog and the transactivation domain from the viral protein VP16 of human herpes virus (Fig. 5A) , and tested its activity on Rex-1 reporter. As shown in Fig. 5B , the chimera is a very robust activator of Rex-1 reporter in NIH3T3, outperforming the wild type Nanog significantly (5B, lanes 4 vs 2). Curiously, the same chimera is less active than the wild type Nanog in P19 cells, suggesting that the C-terminus of Nanog interacts with factors that specifically expressed in P19 or ES cells in mediating Rex-1 activation.
DISSCUSSION
We report here that Nanog can regulate the expression of Rex-1 by binding to its promoter. This regulation is likely mediated by the C-terminal transactivator of Nanog.
Further more, we also demonstrated that Sox2, not Oct4 appears to cooperate with Nanog in regulating Rex-1 activity, suggesting that Rex-1 is under the control of a network of transcription factors.
Rex-1 is regulated by multiple transcription factors. As a well known and much analyzed marker for stem cell pluripotency, Rex-1 has attracted considerable attention recently. However, little is known about why Rex-1 is only expressed in the ES and EC cells (2) . Previously, Oct-3/4 has been identified as a regulator of Rex-1 expression (6). Our findings in this study suggest that two additional factors known to regulate stem cell pluripotency, Nanog and Sox2, also regulate Rex-1 expression. These results reveal for the first time a validated target for Nanog. Furthermore, it appears that Nanog can cooperate with Sox2 in regulating Rex-1 expression. Interestingly, we detected little cooperativity between Oct4 and Nanog, suggesting that these two factors may be functioning in the same pathway. Surprisingly, Oct4 and Sox2, known to regulate fgf4 cooperatively, exhibited no cooperativity towards Rex-1 promoter.
Thus, Nanog, Sox2, and Oct4 may regulate common targets, but through distinct mechanisms.
We reported earlier that Nanog regulates gene transcription through two strong transactivation domains at the C-terminus, the CD2 and W-repeat domains employing synthetic reporters (9, 10) . In this study, we show for the first time that these two C-terminal domains are required for Nanog to activate a natural promoter from an important ES cell marker, Rex-1. While the role of the C-terminal domain of Nanog in maintaining stem cell pluripotency remains unclear, the fact that it is involved in Rex-1 expression suggest that it should play an important role in ES cell self renewal. The interactive partner for the C-terminus of Nanog has not been identified. The Rex-1 promoter based reporter as described in this study may serve as an important tool to evaluate Nanog function at the biochemical level and may help to unravel the role of Nanog in mediating stem cell self renewal and pluripotency. and Nanog expression construct (0.75ug, lanes 2, 4, 6) in NIH3T3 (lanes 1, 2), P19 (lanes 3, 4) and F9 (lanes 5, 6) and the reporter activities measured and presented in bar graphs. The data were analyzed by the student t-test (lane2 vs lane1, lane4 vs lane3 and lane6 vs lane5) and ** indicates a p value <0.01. E: Downregulation of Rexp1500 reporter by Nanog siRNA in F9 cells. The reporter was cotransfected with pU6 (0.5ug, lane 2) and Nanog siRNA construct (0.5ug, lane 3) in F9 cells and the activities measured as described previously. Student t-test shows a P<0.01 (lane3 vs lane2). F: Nanog siRNA inhibits the expression of Nanog in F9 cells. The F9 cells was transfected with pBSU6 (0.5ug per hole, lane2) and Nanog siRNA construct (0.5ug per hole, lane 3) and were analyzed by RT-PCR for the expression of actin and Nanog. , lanes 1, 5, 9, 13, 17; 0.25ug, lanes 2, 6, 10, 14, 18; 0.5ug, lanes 3, 7, 11, 15,  19; and 0.75ug, lanes 4, 8, 12, 16, 20) into P19 cells. The reporter activities were measured and presented in bar graphs. Note the lack of response of Rexp187 to Nanog. C: The mutations at Rexp286. The mutant reporters were constructed and co-transfected with Nanog expression construct into P19 cells ( 0 ug, lanes 1, 5, 9, 13, 17; 0.25ug, lanes 2, 6, 10, 14, 18; 0.5ug, lanes 3, 7, 11, 15, 19; and 0.75ug, lanes 4, 8, 12, 16 5 . Nanog transactivates Rex-1 through its C-terminal domains: A: Schematic illustration of Nanog and its deletion mutant and chimera. ND, N-terminal domain; HD, homeodoam; CD1, C-terminal domain 1; WR, w-repeat; CD2, C-terminal domain 2. B: The Rexp500 promoter (0.25ug plasmid per well) was cotransfected with pCR3.1, Nanog, N1 and Vp16 (0.75ug) into NIH3T3 cells and the reporter activities measured as described in Materials and Methods. Note that Nanog-VP16 is much more active than wild type Nanog (lanes 4 vs 2). N1 is much less effective (lane 3). ** indicates p value <0.01. C: The Rexp500 promoter (0.25ug/well) was cotransfected with pCR3.1, Nanog, N1 and Vp16 into P19 cells and reporter activities measured as in B. ** indicates P<0.01; * P<0.05. 
